ERGOMED Clinical Research

ERGOMED Clinical Research

Founded in 1997, Ergomed is a full-service, global Phase I-IV Clinical Research Organisation with leading expertise in developing oncology and rare disease drugs. Our portfolio includes experience working with novel therapies, early-phase development, immunotherapy, and adaptive trial designs. Ergomed has supported and managed clinical development, trial management, pharmacovigilance, and medical information services for over 300 clients in 100+ countries. We also offer an industry-leading suite of specialist pharmacovigilance solutions by the PrimeVigilance brand.

Clinical Research, Clinical Trials, Drug Development

Yes